Literature DB >> 17635389

Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision.

T Fuchs-Buder1, C Claudius, L T Skovgaard, L I Eriksson, R K Mirakhur, J Viby-Mogensen.   

Abstract

The set of guidelines for good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents, which was developed following an international consensus conference in Copenhagen, has been revised and updated following the second consensus conference in Stockholm in 2005. It is hoped that these guidelines will continue to help researchers in the field and assist the pharmaceutical industry and equipment manufacturers in enhancing the standards of the studies they sponsor.

Mesh：

Substances：

Year:  2007        PMID： 17635389     DOI： 10.1111/j.1399-6576.2007.01352.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN： 0001-5172            Impact factor:   2.105


  123 in total

1.  Mindray 3-directional NMT Module (a new generation "Tri-axial" neuromuscular monitor) versus the Relaxometer mechanomyograph and versus the TOF-Watch SX acceleromyograph.

Authors:  Ashraf A Dahaba; Ismet Suljevic; Zhao Yang Xiao; Kun Wang
Journal:  J Clin Monit Comput       Date:  2018-12-05       Impact factor: 2.502

2.  The relationship between the target effective site concentration of rocuronium and the degree of recovery from neuromuscular blockade in elderly patients.

Authors:  Xiaochong Fan; Minyu Ma; Zhisong Li; Shengkai Gong; Wei Zhang; Yuanyuan Wen
Journal:  Int J Clin Exp Med       Date:  2015-09-15

3.  Positive and negative staircase effect during single twitch and train-of-four stimulation: a laboratory study in dogs.

Authors:  Manuel Martin-Flores; Chia T Tseng; Daniel M Sakai; Marta Romano; Luis Campoy; Robin D Gleed
Journal:  J Clin Monit Comput       Date:  2016-02-16       Impact factor: 2.502

4.  Efficacy of different doses of sugammadex after continuous infusion of rocuronium.

Authors:  Diego Soto Mesa; Mounir Fayad Fayad; Laura Pérez Arviza; Verónica Del Valle Ruiz; Fernando Cosío Carreño; Luis Arguelles Tamargo; Manuel Amorín Díaz; Sergio Fernández-Pello Montes
Journal:  World J Clin Cases       Date:  2015-04-16       Impact factor: 1.337

5.  Effective method of continuous rocuronium administration based on effect-site concentrations using a pharmacokinetic/pharmacodynamic model during propofol-remifentanil anesthesia.

Authors:  Takahiro Moriyama; Akira Matsunaga; Osamu Nagata; Kei Enohata; Tomomi Kamikawaji; Erika Uchino; Yuichi Kanmura
Journal:  J Anesth       Date:  2015-03-01       Impact factor: 2.078

6.  Feasibility of intraoperative neuromonitoring during thyroid surgery after administration of nondepolarizing neuromuscular blocking agents.

Authors:  Koung-Shing Chu; Sheng-Hua Wu; I-Cheng Lu; Cheng-Jing Tsai; Che-Wei Wu; Wen-Rei Kuo; Ka-Wo Lee; Feng-Yu Chiang
Journal:  World J Surg       Date:  2009-07       Impact factor: 3.352

Review 7.  [Sugammadex. New pharmacological concept for antagonizing rocuronium and vecuronium].

Authors:  H J Sparr; L H Booij; T Fuchs-Buder
Journal:  Anaesthesist       Date:  2009-01       Impact factor: 1.041

Review 8.  Avoidance versus use of neuromuscular blocking agents for improving conditions during tracheal intubation or direct laryngoscopy in adults and adolescents.

Authors:  Lars H Lundstrøm; Christophe Hv Duez; Anders K Nørskov; Charlotte V Rosenstock; Jakob L Thomsen; Ann Merete Møller; Søren Strande; Jørn Wetterslev
Journal:  Cochrane Database Syst Rev       Date:  2017-05-17

9.  Optimal remifentanil dosage for intubation without muscle relaxants in elderly patients.

Authors:  Eui-Kyoung Goo; Ah-Young Oh; Suk-Ju Cho; Kwang-Suk Seo; Young-Tae Jeon
Journal:  Drugs Aging       Date:  2012-11       Impact factor: 3.923

Review 10.  Sugammadex: a review of its use in anaesthetic practice.

Authors:  Lily P H Yang; Susan J Keam
Journal:  Drugs       Date:  2009       Impact factor: 9.546
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.